Related Experiment Videos
Localized primary malignant lymphoma of bone
1Department of Radiotherapy, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Summary
The International Index is a valid prognostic tool for primary malignant lymphoma of bone (PLB). Optimal local control for PLB is achieved with radiation doses around 46 Gy.
Area of Science:
- Oncology
- Hematology
- Radiotherapy
Background:
- Primary malignant lymphoma of bone (PLB) is a rare bone malignancy.
- Treatment strategies and prognostic factors for PLB require further elucidation.
Purpose of the Study:
- To analyze a single institution's experience with localized primary malignant lymphoma of bone (PLB).
- To identify key prognostic factors, treatment toxicities, and optimal therapeutic approaches for this rare cancer.
Main Methods:
- Retrospective analysis of 45 previously untreated patients with stage IE and IIE PLB (1967-1992).
- Histopathological review and assessment of International Index scores.
- Survival outcomes (OS, PFS, DSS) calculated actuarially for patients treated with chemotherapy and radiation (CMT), radiation alone, or chemotherapy alone.
Main Results:
- Diffuse large cell lymphoma was the most common histology (41/45 patients).
- Significantly improved 5-year overall survival (OS) was observed for patients with International Index scores of 0 compared to scores of 1 or 2 (85% vs. 53%, p=0.004).
- No significant differences in OS, PFS, or DSS were found when comparing radiotherapy alone versus CMT, stage IE versus IIE, or axial skeleton versus extremity involvement.
Conclusions:
- The outcome for patients with PLB is generally favorable with modern chemotherapy and radiation (CMT).
- Radiation doses of approximately 46 Gy appear optimal for local control with manageable complications.
- The International Index is confirmed as a valid prognostic indicator for primary malignant lymphoma of bone.